Decintas 50 Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Decitabine (50mg)
Overview Decintas 50 Injection
Decintas 50 Injection treats acute myeloid leukemia (AML), a type of blood cancer, and myelodysplastic syndrome (MDS). Other uses may be determined by your physician. This medication is often part of combination chemotherapy, administered intravenously under medical supervision. Dosage and frequency are tailored to your condition and may adjust over time; follow your doctor's instructions precisely. Incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include nausea, vomiting, diarrhea, headache, fever, and pneumonia. The drug can decrease blood cell counts, raising infection risk. Regular blood tests monitoring blood cell levels, heart, liver function, and uric acid are necessary. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of antibiotics or other medications, as drug interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is crucial throughout treatment.
Uses of Decintas 50 Injection
Bone marrow failure disorder; a type of blood cancer.
Major Benefits of Decintas 50 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Decintas 50 Injection:
- Nausea
- Vomiting
- Headache
- Fever
- Lung infection
- Decreased white blood cell count (neutrophils)
- Nosebleeds
- Anemia (low number of red blood cells)
- Low blood platelets
- Diarrhea
- Pneumonia
How to use Decintas 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Decintas 50 Injection works:
Decintas 50 Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential molecular components, thus inhibiting tumor growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Decintas 50 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Decintas 50 Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may be made in extreme circumstances where a physician determines the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Decintas 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Decintas 50 Injection may induce adverse reactions that impair driving capabilities. Fatigue or weakness following Decintas 50 Injection may also compromise driving ability.
KidneyCAUTION
Exercise caution when administering Decintas 50 Injection to individuals with impaired renal function. Dosage modification for Decintas 50 Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Decintas 50 Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Decintas 50 Injection :
NA
Facts to Know About Decintas 50 Injection
| Label | Value |
|---|---|
| Chemical Classification | Azacitidine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Class | Metabolic Antagonists |
3,018 People bought this recently